Loading
2cureX
2cureX's IndiTreat test grows a patient's tumour cells as microtumours and tests approved drugs on them, available through hospitals in Denmark, Germany, Sweden and the United Kingdom.
Overview
2cureX develops products for individualised therapy selection in oncology. Its IndiTreat technology uses 3D cell cultures of the patient's own tumour to test drugs and drug combinations, and is offered through hospitals in Denmark, Germany, Sweden and the UK, physician-ordered.
Connected
2Similar pages
- CompanyCure-First
Shares Functional (ex vivo) drug testing, Patient-derived organoids and the tag fcct-directory.
- CompanySageMedic
Shares Functional (ex vivo) drug testing, Patient-derived organoids and the tag fcct-directory.
- CompanySpeciCare
Shares Functional (ex vivo) drug testing, Patient-derived organoids and the tag fcct-directory.
- CompanyTravera
Shares Functional (ex vivo) drug testing and the tag fcct-directory.
- CompanyKiyatec
Shares Functional (ex vivo) drug testing, Patient-derived organoids and the tag fcct-directory.
- CompanyFirst Ascent Biomedical
Shares Functional (ex vivo) drug testing and the tag fcct-directory.
- CompanyKYAN Technologies
Shares Functional (ex vivo) drug testing and the tag fcct-directory.
- CompanyStoreMyTumor
Shares Functional (ex vivo) drug testing and the tag fcct-directory.
Sources
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
2curex.com · 1
sijbrandijfoundation.org · 1
A source that has moved or gone is reported by the weekly link check. /audit/